<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="6e453a4f-34b9-4f07-92b6-bfc28609ce22"><labelDrug name="ZESTORETIC"><Normalization><mmtx cui="C0292855" preferredWord="Zestoretic" semType="phsu, orch"/></Normalization></labelDrug><generic name="Lisinopril and Hydrochlorothiazide"/><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1" text="ZESTORETIC (Lisinopril and Hydrochlorothiazide) combines an angiotensin converting enzyme inhibitor, lisinopril, and a diuretic, hydrochlorothiazide." type="negative"><entity charOffset="129:148" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="a diuretic, hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="0:10" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.1" text="zestoretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0292855" phraseText="ZESTORETIC" preferredWord="Zestoretic" semType="phsu, orch"/><RxNorm RxCui="85783"/></Normalization></entity><entity charOffset="60:99" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.2" text="angiotensin converting enzyme inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="an angiotensin converting enzyme inhibitor," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="101:111" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.3" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="lisinopril," preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="12:22" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.4" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="(Lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="119:127" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.5" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="a diuretic, hydrochlorothiazide." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="27:46" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.6" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.4" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.5" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.2"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.3"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.4"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.5"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.6"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.3"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.4" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.2"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.5"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.6" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.2"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.5"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.6" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.3"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.4" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.5"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.4" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.6"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.6" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.1.e.5"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.8" text="ZESTORETIC is contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an angiotensin-converting enzyme inhibitor and in patients with hereditary or idiopathic angioedema. " type="negative"><entity charOffset="0:10" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.8.e.0" text="zestoretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0292855" phraseText="ZESTORETIC" preferredWord="Zestoretic" semType="phsu, orch"/><RxNorm RxCui="85783"/></Normalization></entity><entity charOffset="164:203" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.8.e.1" text="angiotensin-converting enzyme inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C3536837" phraseText="with an angiotensin-converting enzyme inhibitor" preferredWord="Angiotensin Converting Enzyme Inhibitor [EPC]" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.8.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.8.e.1"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.9" text="Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs." type="negative"><entity charOffset="131:142" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.9.e.0" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C0599503" phraseText="hypersensitivity to other sulfonamide-derived drugs." preferredWord="Sulfonamide Anti-Infective Agents" semType="orch, antb"/><RxNorm RxCui="1427600"/></Normalization></entity><entity charOffset="15:34" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.9.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Because of the hydrochlorothiazide component," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.9.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.9.e.0"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.12" text="Anaphylactoid and Possibly Related Reactions: Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including ZESTORETIC) may be subject to a variety of adverse reactions, some of them serious." type="negative"><entity charOffset="239:249" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.12.e.0" text="zestoretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0292855" phraseText="ZESTORETIC" preferredWord="Zestoretic" semType="phsu, orch"/><RxNorm RxCui="85783"/></Normalization></entity><entity charOffset="213:227" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.12.e.1" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="65:105" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.12.e.2" text="angiotensin-converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="angiotensin-converting enzyme inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.12.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.12.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.12.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.12.e.0"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.13" text="Head and Neck Angioedema:Angioedema of the face, extremities, lips, tongue, glottis and/or larynx has been reported in patients treated with angiotensin-converting enzyme inhibitors, including lisinopril. " type="negative"><entity charOffset="193:203" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.13.e.0" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="lisinopril." preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="141:181" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.13.e.1" text="angiotensin-converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="treated with angiotensin-converting enzyme inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.13.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.13.e.0"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.17" text="Even in those instances where swelling of only the tongue is involved, without respiratory distress, patients may require prolonged observation since treatment with antihistamines and corticosteroids may not be sufficient. " type="negative"><entity charOffset="165:179" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.17.e.0" text="antihistamines" type="Biomedical_Entity"><Normalization><mmtx cui="C0003360" phraseText="treatment with antihistamines" preferredWord="Antihistamines" semType="phsu, orch"/><RxNorm RxCui="967"/></Normalization></entity><entity charOffset="184:199" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.17.e.1" text="corticosteroids" type="Biomedical_Entity"><Normalization><mmtx cui="C0001617" phraseText="corticosteroids" preferredWord="Adrenal Cortex Hormones" semType="strd, phsu, horm"/><RxNorm RxCui="1427675"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.17.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.17.e.1"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.24" text="The angioedema was diagnosed by procedures including abdominal CT scan or ultrasound, or at surgery, and symptoms resolved after stopping the ACE inhibitor. " type="negative"><entity charOffset="129:137" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.24.e.0" text="stopping" type="Biomedical_Entity"><Normalization><mmtx cui="C0723457" phraseText="resolved after stopping" preferredWord="Stop brand of fluoride" semType="inch, phsu"/><RxNorm RxCui="220037"/></Normalization></entity><entity charOffset="142:155" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.24.e.1" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="the ACE inhibitor." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.24.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.24.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.27" lineNumber="26" text="Anaphylactoid Reactions During Desensitization: Two patients undergoing desensitizing treatment with hymenoptera venom while receiving ACE inhibitors sustained life-threatening anaphylactoid reactions. " type="regular"><entity charOffset="48:60" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.27.e.0" text="Two patients" type="SPAN"/><entity charOffset="101:118" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.27.e.1" text="hymenoptera venom" type="Substance"><Normalization><mmtx cui="C1290000" phraseText="desensitizing treatment with hymenoptera venom" preferredWord="Hymenoptera venom" semType="phsu"/><RxNorm RxCui="390053"/></Normalization></entity><entity charOffset="135:149" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.27.e.2" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="receiving ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="177:200" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.27.e.3" text="anaphylactoid reactions" type="Specific_Interaction"/><entity charOffset="160:176" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.27.e.5" text="life-threatening" type="SPAN"/><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.27.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.27.e.3"><relations><relation type="hasEvidence"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.27.e.0"/></relation><relation type="hasSeverity"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.27.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.27.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.27.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.27.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.27.e.2" evidence="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.27.e.0" severity="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.27.e.5" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.27.e.3" type="Specific_Interaction"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.35" text="Hypotension and Related Effects: Excessive hypotension was rarely seen in uncomplicated hypertensive patients but is a possible consequence of lisinopril use in salt/volume-depleted persons such as those treated vigorously with diuretics or patients on dialysis (See PRECAUTIONS, Drug Interactions and ADVERSE REACTIONS)." type="negative"><entity charOffset="228:237" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.35.e.0" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="with diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="143:153" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.35.e.1" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="a possible consequence of lisinopril use" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.35.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.35.e.0"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.41" text="Such patients should be followed closely for the first two weeks of treatment and whenever the dose of lisinopril and/or diuretic is increased. " type="negative"><entity charOffset="121:129" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.41.e.0" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="103:113" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.41.e.1" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="the dose of lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.41.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.41.e.0"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.45" text="Leukopenia/Neutropenia/Agranulocytosis: Another angiotensin-converting enzyme inhibitor, captopril, has been shown to cause agranulocytosis and bone marrow depression, rarely in uncomplicated patients but more frequently in patients with renal impairment, especially if they also have a collagen vascular disease. " type="negative"><entity charOffset="48:87" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.45.e.0" text="angiotensin-converting enzyme inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C3536837" phraseText="Another angiotensin-converting enzyme inhibitor," preferredWord="Angiotensin Converting Enzyme Inhibitor [EPC]" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><entity charOffset="89:98" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.45.e.1" text="captopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0006938" phraseText="captopril," preferredWord="Captopril" semType="phsu, aapp"/><RxNorm RxCui="1998"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.45.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.45.e.1"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.49" text="Hepatic Failure: Rarely, ACE inhibitors have been associated with a syndrome that starts with cholestatic jaundice or hepatitis and progresses to fulminant hepatic necrosis and (sometimes) death. " type="negative"><entity charOffset="118:127" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.49.e.0" text="hepatitis" type="Biomedical_Entity"><Normalization><mmtx cui="C0795623" phraseText="hepatitis" preferredWord="Hepatitis A Vaccine, Inactivated" semType="phsu, imft"/><RxNorm RxCui="989819"/></Normalization></entity><entity charOffset="25:39" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.49.e.1" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.49.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.49.e.0"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.59" text="Most epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agents. " type="negative"><entity charOffset="168:179" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.59.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="198:221" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.59.e.1" text="antihypertensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="75:91" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.59.e.2" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="to antihypertensive use" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.59.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.59.e.1"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.59.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.59.e.0"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.70" text="Lisinopril and Hydrochlorothiazide" type="negative"><entity charOffset="15:34" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.70.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="0:10" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.70.e.1" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="Lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.70.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.70.e.0"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.71" text="Teratogenicity studies were conducted in mice and rats with up to 90 mg/kg/day of lisinopril (56 times the maximum recommended human dose) in combination with 10 mg/kg/day of hydrochlorothiazide (2.5 times the maximum recommended human dose). " type="negative"><entity charOffset="175:194" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.71.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="of hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="82:92" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.71.e.1" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="of lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.71.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.71.e.0"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.77" text="When pregnancy is detected, discontinue ZESTORETIC as soon as possible (See Lisinopril, Fetal Toxicity)." type="negative"><entity charOffset="40:50" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.77.e.0" text="zestoretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0292855" phraseText="ZESTORETIC as soon" preferredWord="Zestoretic" semType="phsu, orch"/><RxNorm RxCui="85783"/></Normalization></entity><entity charOffset="76:86" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.77.e.1" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="Lisinopril," preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.77.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.77.e.1"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.79" text="Acute Myopia and Secondary Angle-Closure Glaucoma: Hydrochlorothiazide, a sulfonamide, can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma. " type="negative"><entity charOffset="74:85" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.79.e.0" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C3536763" phraseText="a sulfonamide," preferredWord="Sulfonamide [EPC]" semType="phsu"/><RxNorm RxCui="1427600"/></Normalization></entity><entity charOffset="51:70" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.79.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.79.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.79.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.96" lineNumber="76" text="Lithium generally should not be given with thiazides (See PRECAUTIONS, Drug Interactions, Lisinopril and Hydrochlorothiazide)." type="regular"><entity charOffset="43:52" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.96.e.0" text="thiazides" type="Drug_Class"><Normalization><mmtx cui="C0541746" phraseText="given with thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.96.e.1" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium generally" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="25:37" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.96.e.2" text="not be given" type="Caution_Interaction"/><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.96.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.96.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.96.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.96.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.96.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.96.e.0" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.96.e.2" type="Caution_Interaction"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.100" text="Aortic Stenosis/Hypertrophic Cardiomyopathy: As with all vasodilators, lisinopril should be given with caution to patients with obstruction in the outflow tract of the left ventricle." type="negative"><entity charOffset="57:69" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.100.e.0" text="vasodilators" type="Biomedical_Entity"><Normalization><mmtx cui="C0042402" phraseText="As with all vasodilators," preferredWord="Vasodilator Agents" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><entity charOffset="71:81" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.100.e.1" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.100.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.100.e.1"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.101" text="Impaired Renal Function: As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals. " type="negative"><entity charOffset="78:89" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.101.e.0" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><entity charOffset="66:77" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.101.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.101.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.101.e.0"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.102" text="In patients with severe congestive heart failure whose renal function may depend on the activity of the renin-angiotensin-aldosterone system, treatment with angiotensin-converting enzyme inhibitors, including lisinopril, may be associated with oliguria and/or progressive azotemia and rarely with acute renal failure and/or death." type="negative"><entity charOffset="209:219" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.102.e.0" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="lisinopril," preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="110:121" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.102.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="depend on the activity of the renin-angiotensin-aldosterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="157:197" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.102.e.2" text="angiotensin-converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="treatment with angiotensin-converting enzyme inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><entity charOffset="122:133" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.102.e.3" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="depend on the activity of the renin-angiotensin-aldosterone system," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.102.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.102.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.102.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.102.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.102.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.102.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.102.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.102.e.2"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.102.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.102.e.3"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.102.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.102.e.2"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.104" text="Experience with another angiotensin-converting enzyme inhibitor suggests that these increases are usually reversible upon discontinuation of lisinopril and/or diuretic therapy. " type="negative"><entity charOffset="24:63" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.104.e.0" text="angiotensin-converting enzyme inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="Experience with another angiotensin-converting enzyme inhibitor" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><entity charOffset="159:167" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.104.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretic therapy." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="141:151" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.104.e.2" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="usually reversible upon discontinuation of lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.104.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.104.e.1"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.104.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.104.e.2"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.104.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.104.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.106" lineNumber="90" text="Some hypertensive patients with no apparent pre-existing renal vascular disease have developed increases in blood urea and serum creatinine, usually minor and transient, especially when lisinopril has been given concomitantly with a diuretic. " type="regular"><entity charOffset="186:196" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.106.e.0" text="lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="233:241" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.106.e.1" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="concomitantly with a diuretic." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="95:118" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.106.e.2" text="increases in blood urea" type="Specific_Interaction"/><entity charOffset="95:107|123:139" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.106.e.4" text="increases in serum creatinine" type="Specific_Interaction"/><entity charOffset="5:79" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.106.e.6" text="hypertensive patients with no apparent pre-existing renal vascular disease" type="SPAN"><Normalization><mmtx cui="C0268790" phraseText="Some hypertensive patients with no apparent pre-existing renal vascular disease" preferredWord="Renal vascular disorder" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.106.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.106.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.106.e.1"/></relation><relation type="hasContext"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.106.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.106.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.106.ddi.2"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.106.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.106.e.1"/></relation><relation type="hasContext"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.106.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.106.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.106.e.6" ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.106.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.106.e.1" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.106.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.108" lineNumber="90" text="Dosage reduction of lisinopril and/or discontinuation of the diuretic may be required." type="regular"><entity charOffset="0:16" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.108.e.0" text="Dosage reduction" type="Caution_Interaction"/><entity charOffset="20:30" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.108.e.2" text="lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="Dosage reduction of lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="61:69" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.108.e.3" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="discontinuation of the diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="38:53" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.108.e.4" text="discontinuation" type="Caution_Interaction"/><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.108.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.108.e.0"><relations><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.108.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.108.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.108.ddi.2"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.108.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.108.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.108.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.108.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.108.e.3" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.108.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.110" text="Hyperkalemia: In clinical trials hyperkalemia (serum potassium greater than 5.7 mEq/L) occurred in approximately 1.4 percent of hypertensive patients treated with lisinopril plus hydrochlorothiazide. " type="negative"><entity charOffset="53:62" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.110.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="(serum potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="163:198" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.110.e.1" text="lisinopril hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0717824" phraseText="treated with lisinopril plus hydrochlorothiazide." preferredWord="Hydrochlorothiazide / Lisinopril" semType="phsu, orch"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.110.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.110.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113" lineNumber="94" text="Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of potassium-sparing diuretics, potassium supplements and/or potassium-containing salt substitutes. " type="irregular"><entity charOffset="124:151" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113.e.0" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="the concomitant use of potassium-sparing diuretics," preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="153:174" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113.e.1" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements" preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="182:219" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113.e.2" text="potassium-containing salt substitutes" type="Substance"><Normalization><mmtx cui="C0597277" phraseText="potassium-containing salt substitutes." preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0784217" phraseText="potassium-containing salt substitutes." preferredWord="Salt Substitute" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="36:48" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113.e.3" text="hyperkalemia" type="Specific_Interaction"/><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.110" text="Hyperkalemia: In clinical trials hyperkalemia (serum potassium greater than 5.7 mEq/L) occurred in approximately 1.4 percent of hypertensive patients treated with lisinopril plus hydrochlorothiazide. "><entity charOffset="163:198" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.110.e.0" text="lisinopril plus hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0717824" phraseText="treated with lisinopril plus hydrochlorothiazide." preferredWord="Hydrochlorothiazide / Lisinopril" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.111" text="In most cases these were isolated values which resolved despite continued therapy. "/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.112" text="Hyperkalemia was not a cause of discontinuation of therapy. "/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113.e.2"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113.e.2"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113.e.0"/><pair ddi="true" e1="labelDrug" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113.e.1"/></sentence><sentence biomedicalEntities="1" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.115" lineNumber="94" text="ZESTORETIC should be used cautiously, if at all, with these agents and with frequent monitoring of serum potassium (See PRECAUTIONS, Drug Interactions)." type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113" Text="Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of potassium-sparing diuretics, potassium supplements and/or potassium-containing salt substitutes. "/><anaphoraEntity charOffset="54:66" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.115.e.5" text="these agents" type="Expression"/><antecedentEntity charOffset="124:151" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113.e.0" text="potassium-sparing diuretics" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113" Text="Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of potassium-sparing diuretics, potassium supplements and/or potassium-containing salt substitutes. "/><anaphoraEntity charOffset="54:66" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.115.e.5" text="these agents" type="Expression"/><antecedentEntity charOffset="153:174" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113.e.1" text="potassium supplements" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113" Text="Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of potassium-sparing diuretics, potassium supplements and/or potassium-containing salt substitutes. "/><anaphoraEntity charOffset="54:66" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.115.e.5" text="these agents" type="Expression"/><antecedentEntity charOffset="182:219" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.113.e.2" text="potassium-containing salt substitutes" type="Substance"/></anaphoraRelation><entity charOffset="0:10" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.115.e.0" text="ZESTORETIC" type="Drug"><Normalization><mmtx cui="C0292855" phraseText="ZESTORETIC" preferredWord="Zestoretic" semType="phsu, orch"/><RxNorm RxCui="85783"/></Normalization></entity><entity charOffset="21:47" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.115.e.1" text="used cautiously, if at all" type="Caution_Interaction"/><entity charOffset="85:95" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.115.e.3" text="monitoring" type="Caution_Interaction"/><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.115.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.115.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.115.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.115.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.115.ddi.2"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.115.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.115.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.115.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.115.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.115.e.5" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.115.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.118" text="Surgery/Anesthesia: In patients undergoing major surgery or during anesthesia with agents that produce hypotension, lisinopril may block angiotensin II formation secondary to compensatory renin release. " type="negative"><entity charOffset="137:151" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.118.e.0" text="angiotensin ii" type="Biomedical_Entity"><Normalization><mmtx cui="C0003009" phraseText="angiotensin II formation" preferredWord="Angiotensin II" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="116:126" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.118.e.1" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="8:18" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.118.e.2" text="anesthesia" type="Biomedical_Entity"><Normalization><mmtx cui="C0002932" phraseText="Surgery/Anesthesia" preferredWord="Anesthetics" semType="phsu"/><RxNorm RxCui="239756"/></Normalization></entity><entity charOffset="67:77" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.118.e.3" text="anesthesia" type="Biomedical_Entity"><Normalization><mmtx cui="C0002932" phraseText="or during anesthesia" preferredWord="Anesthetics" semType="phsu"/><RxNorm RxCui="239756"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.118.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.118.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.118.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.118.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.118.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.118.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.118.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.118.e.1"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.118.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.118.e.1"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.121" text="Periodic determination of serum electrolytes to detect possible electrolyte imbalance should be performed at appropriate intervals." type="negative"><entity charOffset="32:44" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.121.e.0" text="electrolytes" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="Periodic determination of serum electrolytes to" preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="64:75" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.121.e.1" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="possible electrolyte imbalance" preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.121.e.0" e2=""/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.122" text="All patients receiving thiazide therapy should be observed for clinical signs of fluid or electrolyte imbalance: namely, hyponatremia, hypochloremic alkalosis, and hypokalemia. " type="negative"><entity charOffset="23:31" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.122.e.0" text="thiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="thiazide therapy" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="90:101" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.122.e.1" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="electrolyte imbalance" preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.122.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.122.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.128" lineNumber="108" text="Because lisinopril reduces the production of aldosterone, concomitant therapy with lisinopril attenuates the diuretic-induced potassium loss (See PRECAUTIONS, Drug Interactions, Agents Increasing Serum Potassium)." type="regular"><entity charOffset="83:93" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.128.e.0" text="lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="concomitant therapy with lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="94:104|126:140" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.128.e.1" text="attenuates potassium loss" type="Specific_Interaction"/><entity charOffset="109:117" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.128.e.3" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0354170" phraseText="the diuretic-induced potassium loss" preferredWord="Diuretics with potassium" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.128.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.128.e.1"><relations><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.128.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.128.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.128.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.128.e.3" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.128.e.1" type="Specific_Interaction"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.134" text="In diabetic patients dosage adjustments of insulin or oral hypoglycemic agents may be required. " type="negative"><entity charOffset="43:50" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.134.e.0" text="insulin" type="Biomedical_Entity"><Normalization><mmtx cui="C0021641" phraseText="of insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="54:78" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.134.e.1" text="oral hypoglycemic agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0359086" phraseText="oral hypoglycemic agents" preferredWord="Oral hypoglycemic" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.134.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.134.e.1"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.141" text="Thiazides may decrease urinary calcium excretion. " type="negative"><entity charOffset="31:38" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.141.e.0" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="urinary calcium excretion." preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.141.e.1" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.141.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.141.e.0"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.142" text="Thiazides may cause intermittent and slight elevation of serum calcium in the absence of known disorders of calcium metabolism. " type="negative"><entity charOffset="63:70" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.142.e.0" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C0006675" phraseText="slight elevation of serum calcium" preferredWord="Calcium" semType="bacs, phsu, elii"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.142.e.1" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.142.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.142.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.148" lineNumber="132" text="Hypotension - Patients on Diuretic Therapy: Patients on diuretics and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with lisinopril. " type="regular"><entity charOffset="56:65" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.148.e.0" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="Patients on diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="168:205" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.148.e.1" text="excessive reduction of blood pressure" type="Specific_Interaction"/><entity charOffset="239:249" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.148.e.3" text="lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="with lisinopril." preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.148.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.148.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.148.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.148.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.148.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.148.e.3" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.148.e.1" type="Specific_Interaction"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.149" text="The possibility of hypotensive effects with lisinopril can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with lisinopril. " type="negative"><entity charOffset="177:187" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.149.e.0" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="with lisinopril." preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="44:54" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.149.e.1" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="with lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="100:108" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.149.e.2" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="the diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.149.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.149.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.149.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.149.e.2"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.150" text="If it is necessary to continue the diuretic, initiate therapy with lisinopril at a dose of 5 mg daily, and provide close medical supervision after the initial dose for at least two hours and until blood pressure has stabilized for at least an additional hour (See WARNINGS, and DOSAGE AND ADMINISTRATION). " type="negative"><entity charOffset="35:43" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.150.e.0" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="the diuretic," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="67:77" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.150.e.1" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="therapy with lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.150.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.150.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.151" lineNumber="132" text="When a diuretic is added to the therapy of a patient receiving lisinopril, an additional antihypertensive effect is usually observed (See DOSAGE AND ADMINISTRATION)." type="regular"><entity charOffset="7:15" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.151.e.0" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="a diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="63:73" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.151.e.1" text="lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="added to the therapy of a patient receiving lisinopril," preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="78:112" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.151.e.2" text="additional antihypertensive effect" type="Specific_Interaction"/><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.151.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.151.e.2"><relations><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.151.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.151.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.151.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.151.e.1" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.151.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152" lineNumber="134" text="Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with ACE inhibitors, including lisinopril, may result in deterioration of renal function, including possible acute renal failure. " type="regular"><entity charOffset="127:134" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.0" text="elderly" type="SPAN"/><entity charOffset="136:151" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.1" text="volume-depleted" type="SPAN"/><entity charOffset="199:225" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.2" text="compromised renal function" type="SPAN"/><entity charOffset="248:254" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.3" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="co-administration of NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="266:292" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.4" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors," preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="299:313" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.5" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="with ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="325:335" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.6" text="lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="lisinopril," preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="351:382" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.9" text="deterioration of renal function" type="Specific_Interaction"/><entity charOffset="403:422" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.11" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="possible acute renal failure." preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><classClassMembership drugClass="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.4"/><drugClassMembership drug="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.6" drugClass="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.5"/><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.9"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.5"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.ddi.2"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.11"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.5"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.0, Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.2, Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.1" ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.5" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.152.e.9" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.154" lineNumber="134" text="Monitor renal function periodically in patients receiving lisinopril and NSAID therapy." type="regular"><entity charOffset="58:68" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.154.e.0" text="lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="73:78" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.154.e.1" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAID therapy." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.154.e.2" text="Monitor" type="Caution_Interaction"/><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.154.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.154.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.154.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.154.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.154.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.154.e.1" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.154.e.2" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.155" lineNumber="136" text="The antihypertensive effect of ACE inhibitors, including lisinopril, may be attenuated by NSAIDs." type="regular"><entity charOffset="31:45" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.155.e.0" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="The antihypertensive effect of ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="57:67" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.155.e.1" text="lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="lisinopril," preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="90:96" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.155.e.2" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="attenuated by NSAIDs." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="4:27|76:86" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.155.e.3" text="antihypertensive effect attenuated" type="Specific_Interaction"/><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.155.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.155.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.155.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.155.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.155.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.155.e.2" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.155.e.3" type="Specific_Interaction"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.156" text="Dual Blockade of the Renin-Angiotensin System (RAS)" type="negative"><entity charOffset="27:38" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.156.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="Dual Blockade of the Renin-Angiotensin System" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="5:13" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.156.e.1" text="blockade" type="Biomedical_Entity"><Normalization><mmtx cui="C3540676" phraseText="Dual Blockade of the Renin-Angiotensin System" preferredWord="Blockade" semType="phsu"/><RxNorm RxCui="1423936"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.156.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.156.e.0"/></sentence><sentence biomedicalEntities="3" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157" lineNumber="140" text="Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. " type="irregular"><entity charOffset="30:59" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.0" text="angiotensin receptor blockers" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="61:75" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.1" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="80:89" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="128:139" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.3" text="hypotension" type="Specific_Interaction"/><entity charOffset="141:153" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.5" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="159:184" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.7" text="changes in renal function" type="Specific_Interaction"/><entity charOffset="196:215" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.9" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.0"/></relation><relation type="hasObject"><labelDrug text="ZESTORETIC"/><normalization><mmtx><preferredWord>Zestoretic</preferredWord><phraseText>ZESTORETIC</phraseText><cuiCode>C0292855</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.ddi.2"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.0"/></relation><relation type="hasObject"><labelDrug text="ZESTORETIC"/><normalization><mmtx><preferredWord>Zestoretic</preferredWord><phraseText>ZESTORETIC</phraseText><cuiCode>C0292855</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.ddi.3"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.0"/></relation><relation type="hasObject"><labelDrug text="ZESTORETIC"/><normalization><mmtx><preferredWord>Zestoretic</preferredWord><phraseText>ZESTORETIC</phraseText><cuiCode>C0292855</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.ddi.4"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.9"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.2"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.2"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.0"/><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.2" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.9" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.2" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.9" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.157.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.158" lineNumber="140" text="Closely monitor blood pressure, renal function and electrolytes in patients on ZESTORETIC and other agents that affect the RAS." type="regular"><entity charOffset="8:15" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.158.e.0" text="monitor" type="Caution_Interaction"/><entity charOffset="79:89" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.158.e.2" text="ZESTORETIC" type="Drug"><Normalization><mmtx cui="C0292855" phraseText="on ZESTORETIC" preferredWord="Zestoretic" semType="phsu, orch"/><RxNorm RxCui="85783"/></Normalization></entity><entity charOffset="100:126" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.158.e.3" text="agents that affect the RAS" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="other agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="126263"/></Normalization></entity><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.158.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.158.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.158.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.158.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.158.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.158.e.3" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.158.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.159" lineNumber="142" text="Do not co-administer aliskiren with ZESTORETIC in patients with diabetes. " type="regular"><entity charOffset="0:20" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.159.e.0" text="Do not co-administer" type="Caution_Interaction"/><entity charOffset="21:30" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.159.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with ZESTORETIC" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="36:46" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.159.e.3" text="ZESTORETIC" type="Drug"><Normalization><mmtx cui="C0292855" phraseText="aliskiren with ZESTORETIC" preferredWord="Zestoretic" semType="phsu, orch"/><RxNorm RxCui="85783"/></Normalization></entity><entity charOffset="64:72" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.159.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes." preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes." preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.159.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.159.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.159.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.159.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.159.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.159.e.4" ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.159.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.159.e.3" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.159.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.160" lineNumber="142" text="Avoid use of aliskiren with ZESTORETIC in patients with renal impairment (GFR &lt; 60 ml/min)." type="regular"><entity charOffset="13:22" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.160.e.0" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.160.e.1" text="Avoid use" type="Caution_Interaction"/><entity charOffset="56:72" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.160.e.3" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><entity charOffset="28:38" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.160.e.4" text="ZESTORETIC" type="Drug"><Normalization><mmtx cui="C0292855" phraseText="with ZESTORETIC" preferredWord="Zestoretic" semType="phsu, orch"/><RxNorm RxCui="85783"/></Normalization></entity><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.160.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.160.e.1"><relations><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.160.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.160.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.160.e.3"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.160.e.3" ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.160.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.160.e.4" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.160.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.161" text="Other Agents: Lisinopril has been used concomitantly with nitrates and/or digoxin without evidence of clinically significant adverse interactions. " type="negative"><entity charOffset="14:24" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.161.e.0" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="Lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="74:81" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.161.e.1" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="digoxin without evidence of clinically significant adverse interactions." preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.161.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.161.e.1"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.162" text="No meaningful clinically important pharmacokinetic interactions occurred when lisinopril was used concomitantly with propranolol, digoxin, or hydrochlorothiazide. " type="negative"><entity charOffset="142:161" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.162.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="130:137" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.162.e.1" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="digoxin," preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="117:128" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.162.e.2" text="propranolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033497" phraseText="concomitantly with propranolol," preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="78:88" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.162.e.3" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.162.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.162.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.162.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.162.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.162.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.162.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.162.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.162.e.1"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.162.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.162.e.1"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.162.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.162.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.164" lineNumber="146" text="Agents Increasing Serum Potassium: Lisinopril attenuates potassium loss caused by thiazide-type diuretics. " type="regular"><entity charOffset="35:45" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.164.e.0" text="Lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="Lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="82:105" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.164.e.1" text="thiazide-type diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="caused by thiazide-type diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="46:71" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.164.e.2" text="attenuates potassium loss" type="Specific_Interaction"/><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.164.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.164.e.2"><relations><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.164.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.164.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.164.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.164.e.1" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.164.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="8" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165" lineNumber="146" text="Use of lisinopril with potassium-sparing diuretics (eg, spironolactone, eplerenone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. " type="regular"><entity charOffset="7:17" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.0" text="lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="Use of lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="23:50" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.1" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="with potassium-sparing diuretics" preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="56:70" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.2" text="spironolactone" type="Drug"><Normalization><mmtx cui="C0037982" phraseText="spironolactone," preferredWord="Spironolactone" semType="strd, phsu"/><RxNorm RxCui="9997"/></Normalization></entity><entity charOffset="72:82" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.3" text="eplerenone" type="Drug"><Normalization><mmtx cui="C0961485" phraseText="eplerenone," preferredWord="eplerenone" semType="strd, phsu"/><RxNorm RxCui="298869"/></Normalization></entity><entity charOffset="84:95" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.4" text="triamterene" type="Drug"><Normalization><mmtx cui="C0040869" phraseText="triamterene," preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><entity charOffset="100:109" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.5" text="amiloride" type="Drug"><Normalization><mmtx cui="C0002502" phraseText="amiloride" preferredWord="Amiloride" semType="phsu, orch"/><RxNorm RxCui="142424"/></Normalization></entity><entity charOffset="112:133" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.10" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements," preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="138:175" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.11" text="potassium-containing salt substitutes" type="Substance"><Normalization><mmtx cui="C0597277" phraseText="potassium-containing salt substitutes" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0784217" phraseText="potassium-containing salt substitutes" preferredWord="Salt Substitute" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="200:228" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.12" text="increases in serum potassium" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.2" drugClass="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.1"/><drugClassMembership drug="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.3" drugClass="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.1"/><drugClassMembership drug="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.4" drugClass="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.1"/><drugClassMembership drug="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.5" drugClass="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.1"/><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.12"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.10"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.11"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.1" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.12" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.10" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.12" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.11" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.12" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.10"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.11"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.10" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.11"/></sentence><sentence biomedicalEntities="0" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.166" lineNumber="146" text="Therefore, if concomitant use of these agents is indicated, because of demonstrated hypokalemia, they should be used with caution and with frequent monitoring of serum potassium." type="irregular"><entity charOffset="112:129" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.166.e.0" text="used with caution" type="Caution_Interaction"/><entity charOffset="148:158" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.166.e.2" text="monitoring" type="Caution_Interaction"/><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.166.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.166.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165" text="Use of lisinopril with potassium-sparing diuretics (eg, spironolactone, eplerenone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.1"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165" text="Use of lisinopril with potassium-sparing diuretics (eg, spironolactone, eplerenone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.10"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165" text="Use of lisinopril with potassium-sparing diuretics (eg, spironolactone, eplerenone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.11"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165" text="Use of lisinopril with potassium-sparing diuretics (eg, spironolactone, eplerenone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.166.ddi.2"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.166.e.2"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165" text="Use of lisinopril with potassium-sparing diuretics (eg, spironolactone, eplerenone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.1"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165" text="Use of lisinopril with potassium-sparing diuretics (eg, spironolactone, eplerenone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.10"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165" text="Use of lisinopril with potassium-sparing diuretics (eg, spironolactone, eplerenone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.11"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165" text="Use of lisinopril with potassium-sparing diuretics (eg, spironolactone, eplerenone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. "><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.165.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="3" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.167" lineNumber="148" text="Lithium: Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including ACE inhibitors. " type="regular"><entity charOffset="93:132" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.167.e.0" text="drugs which cause elimination of sodium" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="lithium concomitantly with drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C0597484" phraseText="elimination of sodium," preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="144:158" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.167.e.1" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="17:25" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.167.e.2" text="toxicity" type="Increase_Interaction"/><entity charOffset="9:16" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.167.e.4" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium toxicity" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><classClassMembership drugClass="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.167.e.1"/><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.167.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.167.e.2"><relations><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.167.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.167.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.167.e.4" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.167.e.0" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.167.e.2" type="Increase_Interaction"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.168" text="Lithium toxicity was usually reversible upon discontinuation of lithium and the ACE inhibitor. " type="negative"><entity charOffset="80:93" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.168.e.0" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="the ACE inhibitor." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="64:71" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.168.e.1" text="lithium" type="Biomedical_Entity"><Normalization><mmtx cui="C0023870" phraseText="usually reversible upon discontinuation of lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.168.e.2" text="lithium" type="Biomedical_Entity"><Normalization><mmtx cui="C0023870" phraseText="Lithium toxicity" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.168.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.168.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.168.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.168.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.169" lineNumber="148" text="It is recommended that serum lithium levels be monitored frequently if lisinopril is administered concomitantly with lithium." type="regular"><entity charOffset="47:56" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.169.e.0" text="monitored" type="Caution_Interaction"/><entity charOffset="71:81" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.169.e.2" text="lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="117:124" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.169.e.3" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="concomitantly with lithium." preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.169.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.169.e.0"><relations><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.169.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.169.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.169.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.169.e.3" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.169.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172" lineNumber="154" text="Alcohol, barbiturates, or narcotics - potentiation of orthostatic hypotension may occur." type="irregular"><entity charOffset="38:77" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172.e.0" text="potentiation of orthostatic hypotension" type="Specific_Interaction"><Normalization><mmtx cui="C0149746" phraseText="narcotics - potentiation of orthostatic hypotension" preferredWord="Orthostasis" semType="sosy"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172.e.2" text="Alcohol" type="Substance"><Normalization><mmtx cui="C0001975" phraseText="Alcohol," preferredWord="Alcohols" semType="phsu, orch"/><RxNorm RxCui="448"/></Normalization></entity><entity charOffset="9:21" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172.e.3" text="barbiturates" type="Drug_Class"><Normalization><mmtx cui="C0004745" phraseText="barbiturates," preferredWord="Barbiturates" semType="phsu, orch"/><RxNorm RxCui="1437144"/></Normalization></entity><entity charOffset="26:35" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172.e.4" text="narcotics" type="Drug_Class"><Normalization><mmtx cui="C0027415" phraseText="narcotics - potentiation of orthostatic hypotension" preferredWord="Narcotics" semType="phsu, hops"/><RxNorm RxCui="992359"/></Normalization></entity><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.171" text="When administered concurrently the following drugs may interact with thiazide diuretics."><entity charOffset="69:87" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.171.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172.e.4"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172.e.4"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172.e.3"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.173" lineNumber="156" text="Antidiabetic drugs (oral agents and insulin) - dosage adjustment of the antidiabetic drug may be required." type="irregular"><anaphoraRelation><anaphoraEntity charOffset="72:89" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.173.e.2" text="antidiabetic drug" type="Expression"/><antecedentEntity charOffset="0-31" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.173.e.3" text="Antidiabetic drugs oral agents" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><anaphoraEntity charOffset="72:89" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.173.e.2" text="antidiabetic drug" type="Expression"/><antecedentEntity charOffset="36-43" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.173.e.4" text="insulin" type="Drug"/></anaphoraRelation><entity charOffset="47:64" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.173.e.0" text="dosage adjustment" type="Caution_Interaction"/><entity charOffset="0:18|20:31" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.173.e.3" text="Antidiabetic drugs oral agents" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="Antidiabetic drugs" preferredWord="Antidiabetics" semType="phsu"/><mmtx cui="C1254351" phraseText="(oral agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><entity charOffset="36:43" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.173.e.4" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.173.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.173.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.173.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.171" text="When administered concurrently the following drugs may interact with thiazide diuretics."><entity charOffset="69:87" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.171.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172" text="Alcohol, barbiturates, or narcotics - potentiation of orthostatic hypotension may occur."/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.173.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.174" lineNumber="158" text="Other antihypertensive drugs - additive effect or potentiation." type="irregular"><entity charOffset="31:46" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.174.e.0" text="additive effect" type="Increase_Interaction"/><entity charOffset="50:62" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.174.e.2" text="potentiation" type="Increase_Interaction"/><entity charOffset="6:28" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.174.e.4" text="antihypertensive drugs" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="Other antihypertensive drugs - additive effect" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.174.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.174.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.171" text="When administered concurrently the following drugs may interact with thiazide diuretics."><entity charOffset="69:87" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.171.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172" text="Alcohol, barbiturates, or narcotics - potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.173" text="Antidiabetic drugs (oral agents and insulin) - dosage adjustment of the antidiabetic drug may be required."/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.174.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.174.ddi.2"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.174.e.2"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.171" text="When administered concurrently the following drugs may interact with thiazide diuretics."><entity charOffset="69:87" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.171.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172" text="Alcohol, barbiturates, or narcotics - potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.173" text="Antidiabetic drugs (oral agents and insulin) - dosage adjustment of the antidiabetic drug may be required."/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.174.e.4"/></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.175" text="Cholestyramine and colestipol resins - Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. " type="negative"><entity charOffset="0:14" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.175.e.0" text="cholestyramine" type="Biomedical_Entity"><Normalization><mmtx cui="C0008402" phraseText="Cholestyramine" preferredWord="Cholestyramine Resin" semType="phsu, orch"/><RxNorm RxCui="2447"/></Normalization></entity><entity charOffset="19:29" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.175.e.1" text="colestipol" type="Biomedical_Entity"><Normalization><mmtx cui="C0009279" phraseText="colestipol resins - Absorption of hydrochlorothiazide" preferredWord="Colestipol" semType="phsu, orch"/><RxNorm RxCui="104485"/></Normalization></entity><entity charOffset="53:72" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.175.e.2" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="colestipol resins - Absorption of hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.175.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.175.e.1"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.175.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.175.e.2"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.175.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.175.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176" lineNumber="160" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively." type="regular"><anaphoraRelation><anaphoraEntity charOffset="99:102" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176.e.5" text="its" type="Expression"/><antecedentEntity charOffset="68-87" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176.e.4" text="hydrochlorothiazide" type="Drug"/></anaphoraRelation><entity charOffset="23:37" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176.e.0" text="cholestyramine" type="Drug"><Normalization><mmtx cui="C0008402" phraseText="Single doses of either cholestyramine" preferredWord="Cholestyramine Resin" semType="phsu, orch"/><RxNorm RxCui="2447"/></Normalization></entity><entity charOffset="41:58" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176.e.1" text="colestipol resins" type="Drug_Class"><Normalization><mmtx cui="C0009279" phraseText="colestipol resins" preferredWord="Colestipol" semType="phsu, orch"/><RxNorm RxCui="104485"/></Normalization></entity><entity charOffset="92:98|103:113" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176.e.2" text="reduce absorption" type="Decrease_Interaction"/><entity charOffset="68:87" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176.e.4" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="the hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176.e.5" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176.e.2" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176.e.5" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176.e.2" type="Decrease_Interaction"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.177" lineNumber="162" text="Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia." type="irregular"><entity charOffset="24:57" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.177.e.0" text="intensified electrolyte depletion" type="Specific_Interaction"/><entity charOffset="72:83" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.177.e.2" text="hypokalemia" type="Specific_Interaction"/><entity charOffset="0:15" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.177.e.4" text="Corticosteroids" type="Drug_Class"><Normalization><mmtx cui="C0001617" phraseText="Corticosteroids," preferredWord="Adrenal Cortex Hormones" semType="strd, phsu, horm"/><RxNorm RxCui="1427675"/></Normalization></entity><entity charOffset="17:21" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.177.e.5" text="ACTH" type="Drug"><Normalization><RxNorm RxCui="376"/></Normalization></entity><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.177.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.177.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.177.e.4"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.171" text="When administered concurrently the following drugs may interact with thiazide diuretics."><entity charOffset="69:87" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.171.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172" text="Alcohol, barbiturates, or narcotics - potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.173" text="Antidiabetic drugs (oral agents and insulin) - dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.174" text="Other antihypertensive drugs - additive effect or potentiation."/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.175" text="Cholestyramine and colestipol resins - Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively."/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.177.e.5"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.177.ddi.2"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.177.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.177.e.4"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.171" text="When administered concurrently the following drugs may interact with thiazide diuretics."><entity charOffset="69:87" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.171.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172" text="Alcohol, barbiturates, or narcotics - potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.173" text="Antidiabetic drugs (oral agents and insulin) - dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.174" text="Other antihypertensive drugs - additive effect or potentiation."/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.175" text="Cholestyramine and colestipol resins - Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively."/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.177.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.177.e.4" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.177.e.5"/><pair ddi="true" e1="labelDrug" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.177.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.177.e.5"/></sentence><sentence biomedicalEntities="3" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.178" lineNumber="164" text="Pressor amines (eg, norepinephrine) - possible decreased response to pressor amines but not sufficient to preclude their use." type="irregular"><entity charOffset="20:34" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.178.e.0" text="norepinephrine" type="Drug"><Normalization><mmtx cui="C0028351" phraseText="norepinephrine" preferredWord="Norepinephrine" semType="phsu, orch, nsba"/><RxNorm RxCui="7508"/></Normalization></entity><entity charOffset="0:14" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.178.e.1" text="Pressor amines" type="Drug_Class"><Normalization><mmtx cui="C0237795" phraseText="Pressor amines" preferredWord="Pressors" semType="phsu"/><RxNorm RxCui="203344"/></Normalization></entity><entity charOffset="47:65" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.178.e.3" text="decreased response" type="Decrease_Interaction"/><entity charOffset="69:83" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.178.e.5" text="pressor amines" type="Drug_Class"><Normalization><mmtx cui="C0237795" phraseText="possible decreased response to pressor amines" preferredWord="Pressors" semType="phsu"/><RxNorm RxCui="203344"/></Normalization></entity><drugClassMembership drug="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.178.e.0" drugClass="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.178.e.1"/><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.178.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.178.e.3"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.171" text="When administered concurrently the following drugs may interact with thiazide diuretics."><entity charOffset="69:87" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.171.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172" text="Alcohol, barbiturates, or narcotics - potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.173" text="Antidiabetic drugs (oral agents and insulin) - dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.174" text="Other antihypertensive drugs - additive effect or potentiation."/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.175" text="Cholestyramine and colestipol resins - Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively."/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.177" text="Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia."/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.178.e.5"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.179" lineNumber="166" text="Skeletal muscle relaxants, nondepolarizing (eg, tubocurarine) - possible increased responsiveness to the muscle relaxant." type="irregular"><anaphoraRelation><anaphoraEntity charOffset="105:120" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.179.e.3" text="muscle relaxant" type="Expression"/><antecedentEntity charOffset="0-42" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.179.e.0" text="Skeletal muscle relaxants, nondepolarizing" type="Drug_Class"/></anaphoraRelation><entity charOffset="0:42" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.179.e.0" text="Skeletal muscle relaxants, nondepolarizing" type="Drug_Class"><Normalization><mmtx cui="C0037250" phraseText="Skeletal muscle relaxants," preferredWord="skeletal muscle relaxants" semType="phsu"/><RxNorm RxCui="1427638"/></Normalization></entity><entity charOffset="48:60" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.179.e.1" text="tubocurarine" type="Drug"><Normalization><mmtx cui="C0041345" phraseText="tubocurarine" preferredWord="Tubocurarine" semType="phsu, orch"/><RxNorm RxCui="82115"/></Normalization></entity><entity charOffset="73:97" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.179.e.5" text="increased responsiveness" type="Increase_Interaction"/><drugClassMembership drug="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.179.e.1" drugClass="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.179.e.0"/><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.179.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.179.e.5"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.171" text="When administered concurrently the following drugs may interact with thiazide diuretics."><entity charOffset="69:87" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.171.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.172" text="Alcohol, barbiturates, or narcotics - potentiation of orthostatic hypotension may occur."/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.173" text="Antidiabetic drugs (oral agents and insulin) - dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.174" text="Other antihypertensive drugs - additive effect or potentiation."/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.175" text="Cholestyramine and colestipol resins - Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.176" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively."/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.177" text="Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia."/><middleSentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.178" text="Pressor amines (eg, norepinephrine) - possible decreased response to pressor amines but not sufficient to preclude their use."/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.179.e.3"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.180" lineNumber="168" text="Lithium - should not generally be given with diuretics. " type="regular"><entity charOffset="17:20|31:39" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.180.e.0" text="not be given" type="Caution_Interaction"/><entity charOffset="0:7" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.180.e.2" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium -" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="45:54" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.180.e.3" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="given with diuretics." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.180.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.180.e.0"><relations><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.180.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.180.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.180.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.180.e.3" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.180.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.181" lineNumber="168" text="Diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity. " type="regular"><entity charOffset="16:42" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.181.e.0" text="reduce the renal clearance" type="Increase_Interaction"/><entity charOffset="0:15" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.181.e.2" text="Diuretic agents" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="Diuretic agents" preferredWord="Diuretics" semType="phsu"/><mmtx cui="C1254351" phraseText="Diuretic agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="46:53" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.181.e.3" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="the renal clearance of lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="85:93" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.181.e.4" text="toxicity" type="Increase_Interaction"/><entity charOffset="77:84" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.181.e.6" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="a high risk of lithium toxicity." preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.181.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.181.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.181.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.181.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.181.ddi.2"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.181.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.181.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.181.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.181.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.181.e.3" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.181.e.0" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.181.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.181.e.6" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.181.e.4" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.182" lineNumber="168" text="Refer to the package insert for lithium preparations before use of such preparations with ZESTORETIC." type="regular"><entity charOffset="0:27" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.182.e.0" text="Refer to the package insert" type="Caution_Interaction"/><entity charOffset="32:52" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.182.e.2" text="lithium preparations" type="Drug_Class"><Normalization><mmtx cui="C0023870" phraseText="for lithium preparations" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="90:100" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.182.e.3" text="ZESTORETIC" type="Drug"><Normalization><mmtx cui="C0292855" phraseText="with ZESTORETIC." preferredWord="Zestoretic" semType="phsu, orch"/><RxNorm RxCui="85783"/></Normalization></entity><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.182.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.182.e.0"><relations><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.182.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.182.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.182.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.182.e.3" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.182.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183" lineNumber="170" text="Non-Steroidal Anti-inflammatory Drugs - In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. " type="regular"><entity charOffset="82:119" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.0" text="non-steroidal anti-inflammatory agent" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="the administration of a non-steroidal anti-inflammatory agent" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><mmtx cui="C3536840" phraseText="the administration of a non-steroidal anti-inflammatory agent" preferredWord="Nonsteroidal Anti-inflammatory Drug [EPC]" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="218:236" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.1" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="124:143|179:186" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.2" text="reduce the diuretic effects" type="Specific_Interaction"/><entity charOffset="124:134|145:156|179:186" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.4" text="reduce the natriuretic effects" type="Specific_Interaction"/><entity charOffset="124:134|162:186" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.6" text="reduce the antihypertensive effects" type="Specific_Interaction"/><entity charOffset="190:194|227:236" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.8" text="loop diuretics" type="Drug_Class"><Normalization><mmtx cui="C0597277" phraseText="potassium-sparing" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0012802" phraseText="thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="104215"/></Normalization></entity><entity charOffset="196:213|227:236" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.9" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0597277" phraseText="potassium-sparing" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0012802" phraseText="thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="1437061"/></Normalization></entity><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.2"><relations><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.ddi.2"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.4"><relations><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.9"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.8"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.8"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.8"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.9"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.9"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.ddi.3"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.6"><relations><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.1" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.2" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.9" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.4" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.8" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.4" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.1" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.183.e.4" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.184" lineNumber="170" text="Therefore, when ZESTORETIC and non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of ZESTORETIC is obtained." type="regular"><entity charOffset="16:26" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.184.e.0" text="ZESTORETIC" type="Drug"><Normalization><mmtx cui="C0292855" phraseText="ZESTORETIC" preferredWord="Zestoretic" semType="phsu, orch"/><RxNorm RxCui="85783"/></Normalization></entity><entity charOffset="31:69" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.184.e.1" text="non-steroidal anti-inflammatory agents" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="non-steroidal anti-inflammatory agents" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="116:124" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.184.e.2" text="observed" type="Caution_Interaction"/><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.184.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.184.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.184.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.184.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.184.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.184.e.1" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.184.e.2" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185" lineNumber="172" text="Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including ZESTORETIC." type="regular"><entity charOffset="6:25" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.0" text="Nitritoid reactions" type="Specific_Interaction"><Normalization><mmtx cui="C0948404" phraseText="Nitritoid reactions" preferredWord="Nitritoid reaction" semType="dsyn"/></Normalization></entity><entity charOffset="44:59" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.2" text="facial flushing" type="Specific_Interaction"><Normalization><mmtx cui="C0016382" phraseText="facial flushing," preferredWord="Flushing" semType="sosy"/></Normalization></entity><entity charOffset="61:67" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.4" text="nausea" type="Specific_Interaction"><Normalization><mmtx cui="C0027497" phraseText="nausea," preferredWord="Nausea" semType="sosy"/></Normalization></entity><entity charOffset="69:77" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.6" text="vomiting" type="Specific_Interaction"><Normalization><mmtx cui="C0042963" phraseText="vomiting" preferredWord="Vomiting" semType="sosy"/></Normalization></entity><entity charOffset="82:93" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.8" text="hypotension" type="Specific_Interaction"/><entity charOffset="166:187" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.10" text="sodium aurothiomalate" type="Drug"><Normalization><mmtx cui="C0018034" phraseText="with injectable gold (sodium aurothiomalate" preferredWord="Gold Sodium Thiomalate" semType="phsu, orch"/><RxNorm RxCui="9853"/></Normalization></entity><entity charOffset="205:218" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.11" text="ACE inhibitor" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="concomitant ACE inhibitor therapy" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="237:247" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.12" text="ZESTORETIC" type="Drug"><Normalization><mmtx cui="C0292855" phraseText="ZESTORETIC." preferredWord="Zestoretic" semType="phsu, orch"/><RxNorm RxCui="85783"/></Normalization></entity><drugClassMembership drug="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.12" drugClass="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.11"/><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.0"><relations><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.11"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.10"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.ddi.2"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.2"><relations><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.11"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.10"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.ddi.3"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.4"><relations><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.11"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.10"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.ddi.4"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.6"><relations><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.11"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.10"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.ddi.5"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.8"><relations><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.11"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.10"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.10" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.11" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.185.e.0" type="Specific_Interaction"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.187" text="Lisinopril and Hydrochlorothiazide" type="negative"><entity charOffset="0:10" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.187.e.0" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="Lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="15:34" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.187.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.187.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.187.e.1"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.188" text="Lisinopril in combination with hydrochlorothiazide was not mutagenic in a microbial mutagen test using Salmonella typhimurium (Ames test) or Escherichia coli with or without metabolic activation or in a forward mutation assay using Chinese hamster lung cells. " type="negative"><entity charOffset="0:10" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.188.e.0" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="Lisinopril in combination" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="31:50" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.188.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="with hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.188.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.188.e.1"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.189" text="Lisinopril and hydrochlorothiazide did not produce DNA single strand breaks in an in vitro alkaline elution rat hepatocyte assay. " type="negative"><entity charOffset="15:34" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.189.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="0:10" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.189.e.1" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="Lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.189.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.189.e.0"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.213" text="However, milk of lactating rats contains radioactivity following administration of 14C lisinopril. " type="negative"><entity charOffset="17:26" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.213.e.0" text="lactating" type="Biomedical_Entity"><Normalization><mmtx cui="C0376261" phraseText="milk of lactating rats" preferredWord="Lactate" semType="phsu, orch"/><RxNorm RxCui="114202"/></Normalization></entity><entity charOffset="87:97" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.213.e.1" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="administration of 14C lisinopril." preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.213.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.213.e.1"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.216" text="Because of the potential for serious adverse reactions in nursing infants from ACE inhibitors and hydrochlorothiazide, a decision should be made whether to discontinue nursing and/or discontinue ZESTORETIC, taking into account the importance of the drug to the mother." type="negative"><entity charOffset="195:205" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.216.e.0" text="zestoretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0292855" phraseText="ZESTORETIC," preferredWord="Zestoretic" semType="phsu, orch"/><RxNorm RxCui="85783"/></Normalization></entity><entity charOffset="79:93" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.216.e.1" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="from ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="98:117" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.216.e.2" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.216.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.216.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.216.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.216.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.216.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.216.e.2"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.231" text="Lisinopril monotherapy is an effective treatment of hypertension in once-daily doses of 10-80 mg, while hydrochlorothiazide monotherapy is effective in doses of 12.5 - 50 mg per day. " type="negative"><entity charOffset="0:10" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.231.e.0" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="Lisinopril monotherapy" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="104:123" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.231.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide monotherapy" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.231.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.231.e.1"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.232" text="In clinical trials of lisinopril/hydrochlorothiazide combination therapy using lisinopril doses of 10-80 mg and hydrochlorothiazide doses of 6.25-50 mg, the antihypertensive response rates generally increased with increasing dose of either component." type="negative"><entity charOffset="79:107" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.232.e.0" text="lisinopril 10 mg" type="Biomedical_Entity"><Normalization><mmtx cui="C0987217" phraseText="lisinopril doses of 10-80 mg" preferredWord="Lisinopril 10 MG" semType="clnd"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="157:173" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.232.e.1" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="the antihypertensive response rates generally" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="112:151" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.232.e.2" text="hydrochlorothiazide 6.25 mg" type="Biomedical_Entity"><Normalization><mmtx cui="C0986529" phraseText="hydrochlorothiazide doses of 6.25-50 mg," preferredWord="Hydrochlorothiazide 6.25 MG" semType="clnd"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="22:52" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.232.e.3" text="lisinopril/hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0717824" phraseText="of lisinopril/hydrochlorothiazide combination therapy" preferredWord="Hydrochlorothiazide / Lisinopril" semType="phsu, orch"/><RxNorm RxCui="214618"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.232.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.232.e.1"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.232.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.232.e.2"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.232.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.232.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.232.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.232.e.1"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.232.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.232.e.1"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.232.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.232.e.2"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.235" text="Therapy with any combination of lisinopril and hydrochlorothiazide may be associated with either or both dose-independent or dose-dependent side effects, but addition of lisinopril in clinical trials blunted the hypokalemia normally seen with diuretics." type="negative"><entity charOffset="47:66" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.235.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="243:252" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.235.e.1" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="seen with diuretics." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="170:180" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.235.e.2" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="addition of lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="32:42" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.235.e.3" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="Therapy with any combination of lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.235.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.235.e.1"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.235.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.235.e.2"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.235.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.235.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.235.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.235.e.1"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.235.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.235.e.1"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237" text="Dose Titration Guided by Clinical Effect: A patient whose blood pressure is not adequately controlled with either lisinopril or hydrochlorothiazide monotherapy may be switched to lisinopril/HCTZ 10/12.5 or lisinopril/HCTZ 20/12.5, depending on current monotherapy dose. " type="negative"><entity charOffset="190:194" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.0" text="hctz" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="switched to lisinopril/HCTZ 10/12.5" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="179:189" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.1" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="switched to lisinopril/HCTZ 10/12.5" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="206:216" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.2" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="lisinopril/HCTZ 20/12.5," preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="128:147" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.3" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide monotherapy" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="114:124" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.4" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="controlled with either lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="217:221" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.5" text="hctz" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="lisinopril/HCTZ 20/12.5," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.2"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.4" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.1"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.5"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.2"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.5"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.4" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.3"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.4" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.237.e.5"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.240" text="After addition of the diuretic it may be possible to reduce the dose of lisinopril. " type="negative"><entity charOffset="72:82" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.240.e.0" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="the dose of lisinopril." preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="22:30" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.240.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="of the diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.240.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.240.e.0"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241" text="Patients whose blood pressures are adequately controlled with 25 mg of daily hydrochlorothiazide, but who experience significant potassium loss with this regimen may achieve similar or greater blood-pressure control without electrolyte disturbance if they are switched to lisinopril/HCTZ 10/12.5." type="negative"><entity charOffset="62:96" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.0" text="25 mg hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0986526" phraseText="controlled with 25 mg of daily hydrochlorothiazide," preferredWord="Hydrochlorothiazide 25 MG" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="283:287" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.1" text="hctz" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="switched to lisinopril/HCTZ 10/12.5." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="224:235" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.2" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="greater blood-pressure control without electrolyte disturbance" preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="129:138" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.3" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="significant potassium loss with this regimen" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="272:282" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.4" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="switched to lisinopril/HCTZ 10/12.5." preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.1"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.2"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.3"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.4"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.1"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.1"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.4" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.1"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.2"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.4"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.241.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.242" lineNumber="226" text="In patients who are currently being treated with a diuretic, symptomatic hypotension occasionally may occur following the initial dose of lisinopril. " type="regular"><entity charOffset="51:59" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.242.e.0" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="treated with a diuretic, symptomatic hypotension occasionally" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="138:148" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.242.e.1" text="lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="the initial dose of lisinopril." preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="61:84" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.242.e.2" text="symptomatic hypotension" type="Specific_Interaction"/><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.242.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.242.e.2"><relations><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.242.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.242.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.242.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.242.e.1" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.242.e.2" type="Specific_Interaction"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.243" text="The diuretic should, if possible, be discontinued for two to three days before beginning therapy with lisinopril to reduce the likelihood of hypotension (See WARNINGS). " type="negative"><entity charOffset="4:12" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.243.e.0" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="The diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="102:112" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.243.e.1" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="with lisinopril to" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.243.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.243.e.1"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.244" text="If the patient's blood pressure is not controlled with lisinopril alone, diuretic therapy may be resumed." type="negative"><entity charOffset="55:65" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.244.e.0" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="controlled with lisinopril alone, diuretic therapy" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="73:81" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.244.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="controlled with lisinopril alone, diuretic therapy" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.244.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.244.e.1"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.245" text="If the diuretic cannot be discontinued, an initial dose of 5 mg of lisinopril should be used under medical supervision for at least two hours and until blood pressure has stabilized for at least an additional hour (See WARNINGS and PRECAUTIONS, Drug Interactions)." type="negative"><entity charOffset="59:77" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.245.e.0" text="5 mg lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0987222" phraseText="an initial dose of 5 mg of lisinopril" preferredWord="Lisinopril 5 MG" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="7:15" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.245.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="the diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.245.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.245.e.0"/></sentence><sentence biomedicalEntities="4" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246" lineNumber="230" text="Concomitant administration of ZESTORETIC with potassium supplements, potassium salt substitutes or potassium-sparing diuretics may lead to increases of serum potassium (See PRECAUTIONS)." type="regular"><entity charOffset="30:40" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.0" text="ZESTORETIC" type="Drug"><Normalization><mmtx cui="C0292855" phraseText="Concomitant administration of ZESTORETIC" preferredWord="Zestoretic" semType="phsu, orch"/><RxNorm RxCui="85783"/></Normalization></entity><entity charOffset="46:67" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.1" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="with potassium supplements," preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="69:95" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.2" text="potassium salt substitutes" type="Substance"><Normalization><mmtx cui="C0597277" phraseText="potassium salt substitutes" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0784217" phraseText="potassium salt substitutes" preferredWord="Salt Substitute" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="99:126" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.3" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="potassium-sparing diuretics" preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="139:167" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.4" text="increases of serum potassium" type="Specific_Interaction"/><drugInteraction id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.ddi.1"><interaction trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.3" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.4" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.2" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.4" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.1" trigger="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.4" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.2" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.3"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.3"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.246.e.2"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.248" text="Use in Renal Impairment: Regimens of therapy with lisinopril/HCTZ need not take account of renal function as long as the patient's creatinine clearance is &gt;30 mL/min/1.7m2 (serum creatinine roughly  3 mg/dL or 265  mol/L). " type="negative"><entity charOffset="61:65" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.248.e.0" text="hctz" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="with lisinopril/HCTZ" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="50:60" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.248.e.1" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="with lisinopril/HCTZ" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.248.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.248.e.0"/></sentence><sentence id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.249" text="In patients with more severe renal impairment, loop diuretics are preferred to thiazides, so lisinopril/HCTZ is not recommended (see WARNINGS, Anaphylactoid Reactions During Membrane Exposure)." type="negative"><entity charOffset="79:88" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.249.e.0" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="preferred to thiazides," preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="47:61" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.249.e.1" text="loop diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0354100" phraseText="loop diuretics" preferredWord="Loop Diuretics" semType="phsu"/><RxNorm RxCui="104215"/></Normalization></entity><entity charOffset="104:108" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.249.e.2" text="hctz" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="lisinopril/HCTZ" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="93:103" id="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.249.e.3" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="lisinopril/HCTZ" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.249.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.249.e.0"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.249.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.249.e.2"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.249.e.0" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.249.e.3"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.249.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.249.e.2"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.249.e.1" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.249.e.3"/><pair ddi="false" e1="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.249.e.3" e2="Dailymed.6e453a4f-34b9-4f07-92b6-bfc28609ce22.s.249.e.2"/></sentence><positiveExamples number="50"/><negativeExamples number="141"/></document>